Home › Companies › Biotechnology, Health Care, Market Research, Medical, Therapeutics › Orega Biotech
Orega Biotech
Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer.
Orega Biotech is active in the biotechnology, health care, market research, medical, therapeutics space based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2010.
The company sits in the biotechnology, health care, market research, medical, therapeutics segment, where it competes on its core product or service.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $3.7M.
| Sector | Biotechnology, Health Care, Market Research, Medical, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2010 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $3,710,000 |
Website: orega-biotech.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account